- Home
- ETW vs MRVI Comparison
ETW vs MRVI Comparison
Compare ETW & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
ETW
Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest
Current Price
Company Overview
Basic Information| Metric | ETW | MRVI |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ETW | MRVI |
|---|---|---|
| Price | $9.25 | $7.53 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 215.9K | ★ 2.3M |
| Earning Date | 01-01-0001 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $185,743,000.00 |
| Revenue This Year | N/A | $14.01 |
| Revenue Next Year | N/A | $6.20 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.46 | $2.80 |
| 52 Week High | $9.95 | $9.42 |
Technical Indicators
Market Signals| Indicator | ETW | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 39.40 | 49.67 |
| Support Level | $8.46 | $6.41 |
| Resistance Level | $9.57 | $7.60 |
| Average True Range (ATR) | 0.13 | 0.58 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 7.77 | 37.30 |
Price Performance
Historical ComparisonAbout ETW Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest
Eaton Vance Tax-mangd Glo Buy-write Oppo is a United States-based diversified, closed-end management investment company. The primary investment objective of the company is to provide current income and gains. The secondary objective of the fund is capital appreciation. The fund invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of capital markets, chemicals, banks, biotechnology, media, and other sectors.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.